# Development of in vivo gene therapy for sickle cell disease

Canonical: https://abierto.us/opportunities/75n92024q1081

- Solicitation number: 75N92024Q1081
- Notice type: Presolicitation
- Status: Closed. Deadline was August 21, 2024 at 3:00 PM EDT
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health Nhlbi (75N920)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: Q301 Reference Laboratory Testing
- First posted: August 14, 2024
- Last posted: August 14, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/fa317c5b09104a8b8207163780de61ce/view

## Description

Development of in vivo gene therapy for sickle cell disease

## Publications

- August 14, 2024: Presolicitation, due August 21, 2024 at 3:00 PM EDT. Notice fa317c5b09104a8b8207163780de61ce. https://sam.gov/workspace/contract/opp/fa317c5b09104a8b8207163780de61ce/view

## Points of contact

- Winffel, Helmut, helmut.winffel@nih.gov, 301-435-0330

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n92024q1081.